MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON‐BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA
Abramson, J. S., Bengston, E. M., Redd, R., Barnes, J. A., Takvorian, T., Sokol, L., Lansigan, F., Armand, P., Shah, B., Jacobsen, E., Martignetti, R., Turba, E., Metzler, S. R., Patterson, V., LaCasce, A. S., Bello, C. M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article